Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DAIICHI SANKYO INC

  • FDA Approval
  • Nov. 17, 2023, 13:48 UTC
  • 36
  • 0 comments

FDA approve PEXIDARTINIB HYDROCHLORIDE

Comment Full text

ASTRAZENECA PHARMS

  • FDA Approval
  • Nov. 17, 2023, 13:38 UTC
  • 37
  • 0 comments

FDA approve CAPIVASERTIB

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Nov. 17, 2023, 09:42 UTC
  • 25
  • 0 comments

FDA approve TALQUETAMAB-TGVS

Comment Full text

EPIZYME INC

  • FDA Approval
  • Nov. 17, 2023, 09:42 UTC
  • 35
  • 0 comments

FDA approve TAZEMETOSTAT HYDROBROMIDE

Comment Full text

INSTITUT BIOCHIMIQUE

  • FDA Approval
  • Nov. 17, 2023, 09:42 UTC
  • 30
  • 0 comments

FDA approve LEVOTHYROXINE SODIUM

Comment Full text

MICRO LABS

  • FDA Approval
  • Nov. 17, 2023, 09:42 UTC
  • 31
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

RHYTHM

  • FDA Approval
  • Nov. 17, 2023, 09:42 UTC
  • 30
  • 0 comments

FDA approve SETMELANOTIDE ACETATE

Comment Full text

BRISTOL-MYERS SQUIBB CO

  • FDA Approval
  • Nov. 16, 2023, 15:59 UTC
  • 35
  • 0 comments

FDA approve REPOTRECTINIB

Comment Full text

GLAXOSMITHKLINE CONS

  • FDA Approval
  • Nov. 16, 2023, 09:38 UTC
  • 31
  • 0 comments

FDA approve FLUTICASONE PROPIONATE

Comment Full text

GLAXOSMITHKLINE CONS

  • FDA Approval
  • Nov. 16, 2023, 09:38 UTC
  • 31
  • 0 comments

FDA approve FLUTICASONE FUROATE

Comment Full text
  • Previous
  • 634
  • 635
  • 636
  • 637
  • 638
  • Next

Search

News categories

  • Technical Exchange News(11963)
  • Event(4952)
  • SEC News(246336)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148429)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin